Last edition
News about "monoclonal antibody "
Spyre Therapeutics Initiates Dosing of First Participant in Phase 1 Trial of SPY003
The SPY003 Phase 1 Trial (NCT06873724) is a double-blind, placebo-controlled single-ascending dose study in healthy volunteers.
Monoclonal Antibody | 31/03/2025 | By Aishwarya
Syngene Acquires its First Manufacturing Facility in US
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services.
Monoclonal Antibody | 11/03/2025 | By Aishwarya
GBI and Allterum to Manufacture Therapeutic Antibody for Clinical Trials
With this collaboration, GBI will leverage their extensive expertise in manufacturing complex biologics to ensure the high-quality production of 4A10 for Phase 1/2a clinical trials.
Monoclonal Antibody | 08/10/2024 | By Aishwarya
Sanofi Begins Shipping BEYFORTUS in US
Sanofi has started shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its vaccines for children program.
Monoclonal Antibody | 18/09/2024 | By Aishwarya | 140
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy